WHO ICTRP trial
The effect of letrozole on endometrial thickness in endometriosis IVF parients
IRCT20091012002576N26 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20091012002576N26 |
|---|---|
| Public title | The effect of letrozole on endometrial thickness in endometriosis IVF parients |
| Scientific title | The effect of letrozole on endometrial thickness in endometriosis parients who are candidate for IVF |
| Primary sponsor | Tehran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Infertility. Female infertility of other origin;N97.8 |
| Interventions | Intervention 1: Intervention group: Two tablets of letrozole 2.5 mg(Aboureihan pharmaceutical) will be used from second day of induction ovulation and continued for five days then induction continued by fixed antagonist protocol at 5th day… |
| Registration date | Sep 13, 2022 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: